Onconetix Stock Price on September 17, 2024
| ONCO Stock | USD 1.13 0.05 4.63% |
If you're considering investing in Onconetix Stock, it is important to understand the factors that can impact its price. As of today, the current price of Onconetix stands at 1.13, as last reported on the 22nd of November, with the highest price reaching 1.17 and the lowest price hitting 1.05 during the day. Onconetix maintains Sharpe Ratio (i.e., Efficiency) of -0.14, which implies the firm had a -0.14% return per unit of risk over the last 3 months. Onconetix exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Onconetix's Coefficient Of Variation of (671.47), variance of 172.18, and Risk Adjusted Performance of (0.10) to confirm the risk estimate we provide.
At this time, Onconetix's Total Stockholder Equity is very stable compared to the past year. As of the 22nd of November 2024, Liabilities And Stockholders Equity is likely to grow to about 93.3 M, while Common Stock Shares Outstanding is likely to drop about 13.7 M. . As of the 22nd of November 2024, Price To Sales Ratio is likely to drop to 1,854. In addition to that, Price Earnings Ratio is likely to drop to -3.8. Onconetix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Onconetix |
Sharpe Ratio = -0.142
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ONCO |
Estimated Market Risk
| 13.32 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.89 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Onconetix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Onconetix by adding Onconetix to a well-diversified portfolio.
Price Book 0.3058 | Enterprise Value Ebitda (0.47) | Price Sales 6.4035 | Shares Float 313.7 K | Wall Street Target Price 9 |
Related Headline
Hudson Pacific Headline on 17th of September 2024
Acquisition by Arthur Suazo of 34124 shares of Hudson Pacifi... by Arthur Suazo
Filed transaction by Hudson Pacific Properties Officer Evp, Leasing. Grant, award or other acquisition pursuant to Rule 16b-3
Onconetix Valuation on September 17, 2024
It is possible to determine the worth of Onconetix on a given historical date. On September 17, 2024 Onconetix was worth 5.08 at the beginning of the trading date compared to the closed value of 5.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Onconetix stock. Still, in general, we apply an absolute valuation method to find Onconetix's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Onconetix where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Onconetix's related companies.
| Open | High | Low | Close | Volume | |
| 4.90 | 5.25 | 4.82 | 4.84 | 13,034 | |
09/17/2024 | 5.08 | 5.16 | 4.80 | 5.04 | 8,993 |
| 4.88 | 5.00 | 4.72 | 4.72 | 5,277 |
| Backtest Onconetix | | | Onconetix History | | | Onconetix Valuation | Previous | Next |
Onconetix Trading Date Momentum on September 17, 2024
| On September 18 2024 Onconetix was traded for 4.72 at the closing time. The top price for the day was 5.00 and the lowest listed price was 4.72 . The trading volume for the day was 5.3 K. The trading history from September 18, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 6.35% . The trading delta at closing time against the current closing price is 24.21% . |
Onconetix Fundamentals Correlations and Trends
By evaluating Onconetix's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Onconetix's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Onconetix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Onconetix Stock history
Onconetix investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Onconetix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Onconetix will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Onconetix stock prices may prove useful in developing a viable investing in Onconetix
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 17.1 M | 13.7 M |
Onconetix Stock Technical Analysis
Onconetix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Onconetix Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Onconetix cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Onconetix November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Onconetix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Onconetix shares will generate the highest return on investment. By undertsting and applying Onconetix stock market strength indicators, traders can identify Onconetix entry and exit signals to maximize returns
Onconetix Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Onconetix's price direction in advance. Along with the technical and fundamental analysis of Onconetix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Onconetix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (2.17) | |||
| Total Risk Alpha | (3.68) | |||
| Treynor Ratio | (0.97) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Onconetix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Onconetix. If investors know Onconetix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Onconetix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (109.20) | Revenue Per Share 2.892 | Return On Assets (0.22) | Return On Equity (17.58) |
The market value of Onconetix is measured differently than its book value, which is the value of Onconetix that is recorded on the company's balance sheet. Investors also form their own opinion of Onconetix's value that differs from its market value or its book value, called intrinsic value, which is Onconetix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Onconetix's market value can be influenced by many factors that don't directly affect Onconetix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Onconetix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Onconetix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Onconetix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.